Leucine
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $7M
Investors
- 4
About Leucine
Based in New York, US, and founded in 2019 by CEO Vivek Gera and and CPO Mushtaq Singh, Leucine, Inc. operates as a developer of an artificial intelligence-based platform to manage compliance and audit for pharmaceutical manufacturers. In October 2023, Leucine, Inc. The company offers an integrated dashboard platform to generate insights, transfer compliance risks, and improve productivity for pharmaceutical manufacturers. The company offers a variety of product solutions such as batch planning, material tracking, batch execution, product changeover, quality metrics, investigations, cleaning validation, QC planning, batch release, sample testing, and many more. In addition, the firm provides a wide range of platforms for various roles including Leucine10x, GxP compliant process builder, analytics and reporting, ontology and process interlocks, immutable logbooks, and integrations.'s client base includes Lupin, Mylan, Stelis, Cipla, Tenshi, Piramal, etc.
Who invested in Leucine
4 investors across 1 round
See all investors in Leucine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 16, 2023
Amount
$7M
Investors
Questions about Leucine
Who invested in Leucine?
Leucine has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leucine raised?
Leucine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Leucine last raise money?
Leucine's most recent round on record is a Series A, in Oct 2023.
What does Leucine do?
Based in New York, US, and founded in 2019 by CEO Vivek Gera and and CPO Mushtaq Singh, Leucine, Inc.
Where is Leucine headquartered?
Leucine is headquartered in New York, US.
Which VCs invest in companies like Leucine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Leucine's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Leucine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.